MONDAY, May 17, 2021 (HealthDay News) — Sanofi and GlaxoSmithKline announced Monday that their coronavirus vaccine candidate produced powerful responses in a preliminary trial that followed an earlier setback in the vaccine’s development. In selected data that has not yet been published in a peer-reviewed journal, the vaccine “triggered strongContinue Reading

FRIDAY, May 14, 2021 (HealthDay News) — A single dose of a COVID-19 vaccine isn’t enough to develop adequate antibodies in kidney dialysis patients, Canadian researchers report. “We advise that the second dose of the [Pfizer] vaccine be administered to patients receiving hemodialysis at the recommended 3-week time interval andContinue Reading